{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:25:05Z","timestamp":1790825105920,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200678"],"award-info":[{"award-number":["82200678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900543"],"award-info":[{"award-number":["81900543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030021"],"award-info":[{"award-number":["82030021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 01322"],"award-info":[{"award-number":["2021 SGR 01322"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 PROD 00036"],"award-info":[{"award-number":["2021 PROD 00036"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507500"],"award-info":[{"award-number":["2023YFC2507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI23\/00945"],"award-info":[{"award-number":["FIS PI23\/00945"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS22\/00010"],"award-info":[{"award-number":["DTS22\/00010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1053\/j.gastro.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:39:48Z","timestamp":1718797188000},"page":"993-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension"],"prefix":"10.1053","volume":"167","author":[{"given":"Chang-Peng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peio","family":"Aristu-Zabalza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Boyer-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-4089","authenticated-orcid":false,"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-112X","authenticated-orcid":false,"given":"Wei-Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2024.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107626","article-title":"Novel therapeutics for portal hypertension and fibrosis in chronic liver disease","volume":"215","author":"Guixe-Muntet","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.06.007_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cld.2019.07.007","article-title":"Portal hypertension: pathogenesis and diagnosis","volume":"23","author":"Turco","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2024.06.007_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cld.2019.06.004","article-title":"Pharmacologic management of portal hypertension","volume":"23","author":"Bunchorntavakul","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2024.06.007_bib5","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2024.06.007_bib6","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10181","key":"10.1053\/j.gastro.2024.06.007_bib8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2024.06.007_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12072-021-10135-4","article-title":"Regression of portal hypertension: underlying mechanisms and therapeutic strategies","volume":"15","author":"Selicean","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2024.06.007_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.06.007_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib13","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3748\/wjg.v21.i9.2582","article-title":"Hepatosplanchnic circulation in cirrhosis and sepsis","volume":"21","author":"Prin","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.06.007_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2017.51","article-title":"Non-conventional features of peripheral serotonin signalling\u2014the gut and beyond","volume":"14","author":"Spohn","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2008.01.006","article-title":"The function of serotonin within the liver","volume":"48","author":"Ruddell","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2004.10.002","article-title":"Autocrine\/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin","volume":"128","author":"Marzioni","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.06.007_bib17","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00018-007-7377-3","article-title":"Role of serotonin in the hepato-gastrointestinal tract: an old molecule for new perspectives","volume":"65","author":"Lesurtel","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.gastro.2024.06.007_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.06.007_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1053\/j.gastro.2024.06.007_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.33549\/physiolres.931903","article-title":"Serotonin receptors\u2014from molecular biology to clinical applications","volume":"60","author":"Pytliak","year":"2011","journal-title":"Physiol Res"},{"issue":"6134","key":"10.1053\/j.gastro.2024.06.007_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/329075a0","article-title":"An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins","volume":"329","author":"Kobilka","year":"1987","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.06.007_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10571-005-3969-3","article-title":"The serotonin1A receptor: a representative member of the serotonin receptor family","volume":"25","author":"Pucadyil","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1053\/j.gastro.2024.06.007_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107937","article-title":"Translating biased agonists from molecules to medications: serotonin 5-HT1A receptor functional selectivity for CNS disorders","volume":"229","author":"Newman-Tancredi","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.06.007_bib24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cellsig.2010.03.019","article-title":"5-HT1A receptor-regulated signal transduction pathways in brain","volume":"22","author":"Polter","year":"2010","journal-title":"Cell Signal"},{"key":"10.1053\/j.gastro.2024.06.007_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/sj.bjp.0707496","article-title":"Evolving mechanisms of action of alverine citrate on phasic smooth muscles","volume":"152","author":"Hayase","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.gastro.2024.06.007_bib26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.14309\/ajg.0000000000001266","article-title":"Antispasmodics for chronic abdominal pain: analysis of North American treatment options","volume":"116","author":"Brenner","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.06.007_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2009.04216.x","article-title":"Clinical trial: the efficacy of alverine citrate\/simeticone combination on abdominal pain\/discomfort in irritable bowel syndrome\u2014a randomized, double-blind, placebo-controlled study","volume":"31","author":"Wittmann","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.06.007_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/ijcp.12333","article-title":"On-demand treatment with alverine citrate\/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study","volume":"68","author":"Ducrotte","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.gastro.2024.06.007_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1211\/0022357011777783","article-title":"Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype","volume":"53","author":"Coelho","year":"2001","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1053\/j.gastro.2024.06.007_bib30","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/nprot.2014.171","article-title":"CRISPR\/Cas-mediated genome editing in the rat via direct injection of one-cell embryos","volume":"9","author":"Shao","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1053\/j.gastro.2024.06.007_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm1666","article-title":"G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension","volume":"14","author":"Wirth","year":"2008","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2024.06.007_bib32","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1172\/JCI93868","article-title":"Preexisting endothelial cells mediate cardiac neovascularization after injury","volume":"127","author":"He","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2024.06.007_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.2008.174904","article-title":"Hepatocyte nuclear factor 4\u03b1 attenuates hepatic fibrosis in rats","volume":"59","author":"Yue","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.06.007_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1986.tb11150.x","article-title":"Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats","volume":"89","author":"Cummings","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.gastro.2024.06.007_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820961287","article-title":"Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem","volume":"13","author":"Vidal-Gonzalez","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2024.06.007_bib36","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.06.007_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.122.20109","article-title":"Vascular smooth muscle TRPV4 (transient receptor potential vanilloid family member 4) channels regulate vasoconstriction and blood pressure in obesity","volume":"80","author":"Zhu","year":"2023","journal-title":"Hypertension"},{"key":"10.1053\/j.gastro.2024.06.007_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.gastro.2024.06.007_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2018.00151","article-title":"Endothelial-vascular smooth muscle cells interactions in atherosclerosis","volume":"5","author":"Li","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.gastro.2024.06.007_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/med.21270","article-title":"Myosin light chain kinase signaling in endothelial barrier dysfunction","volume":"33","author":"Rigor","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1053\/j.gastro.2024.06.007_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.abb.2011.02.024","article-title":"Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure","volume":"510","author":"Cole","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1053\/j.gastro.2024.06.007_bib42","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.12659\/MSM.900152","article-title":"Phosphorylated myosin light chain 2 (p-MLC2) as a molecular marker of antemortem coronary artery spasm","volume":"22","author":"Li","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1053\/j.gastro.2024.06.007_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1124\/pr.116.013078","article-title":"International Union of Basic and Clinical Pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases","volume":"69","author":"Dessauer","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1053\/j.gastro.2024.06.007_bib44","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.7150\/thno.55986","article-title":"Role of serotonin receptor signaling in cancer cells and anti-tumor immunity","volume":"11","author":"Karmakar","year":"2021","journal-title":"Theranostics"},{"key":"10.1053\/j.gastro.2024.06.007_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.1840200405","article-title":"Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis","volume":"20","author":"Beaudry","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.06.007_bib46","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3748\/wjg.v13.i43.5750","article-title":"Plasma and platelet serotonin levels in patients with liver cirrhosis","volume":"13","author":"Culafic","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.06.007_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2006.050767","article-title":"A\u00a0role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis","volume":"169","author":"Ruddell","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2024.06.007_bib48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.1840070405","article-title":"Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension","volume":"7","author":"Hadengue","year":"1987","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.06.007_bib49","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0016-5085(88)80084-2","article-title":"ICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats","volume":"95","author":"Kaumann","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.06.007_bib50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840090114","article-title":"Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients","volume":"9","author":"Vorobioff","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.06.007_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0016-5085(90)91302-M","article-title":"Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats","volume":"98","author":"Mastai","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.06.007_bib52","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.1840140636","article-title":"Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats","volume":"14","author":"Nevens","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.06.007_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.06.007_bib54","article-title":"Beta-blockers in cirrhosis: evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2020","journal-title":"JHEP Rep"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524050625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524050625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:15:18Z","timestamp":1726758918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524050625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0016508524050625"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2024.06.007","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}